<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Brain Behav</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Behav</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2157-9032</journal-id>
<journal-id journal-id-type="publisher-id">BRB3</journal-id>
<journal-title-group>
<journal-title>Brain and Behavior</journal-title>
</journal-title-group>
<issn pub-type="epub">2162-3279</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30929312</article-id>
<article-id pub-id-type="pmc">6520293</article-id>
<article-id pub-id-type="doi">10.1002/brb3.1250</article-id>
<article-id pub-id-type="publisher-id">BRB31250</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Research</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epilepsy and genetic in Rett syndrome: A review</article-title>
<alt-title alt-title-type="left-running-head">OPERTO et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="brb31250-cr-0001">
<name>
<surname>Operto</surname>
<given-names>Francesca Felicia</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2444-8761</contrib-id>
<address>
<email>opertofrancesca@gmail.com</email>
</address>
<xref ref-type="aff" rid="brb31250-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31250-cr-0002">
<name>
<surname>Mazza</surname>
<given-names>Roberta</given-names>
</name>
<xref ref-type="aff" rid="brb31250-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31250-cr-0003">
<name>
<surname>Pastorino</surname>
<given-names>Grazia Maria Giovanna</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0404-5495</contrib-id>
<xref ref-type="aff" rid="brb31250-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31250-cr-0004">
<name>
<surname>Verrotti</surname>
<given-names>Alberto</given-names>
</name>
<xref ref-type="aff" rid="brb31250-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="brb31250-cr-0005">
<name>
<surname>Coppola</surname>
<given-names>Giangennaro</given-names>
</name>
<xref ref-type="aff" rid="brb31250-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="brb31250-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Child Neuropsychiatry Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs</named-content>
<institution>University of Bari “Aldo Moro”</institution>
<named-content content-type="city">Bari</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31250-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Child and Adolescent Neuropsychiatry, Medical School</named-content>
<institution>University of Salerno</institution>
<named-content content-type="city">Fisciano</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="brb31250-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>University of L'Aquila</institution>
<named-content content-type="city">Coppito</named-content>
<country country="IT">Italy</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Francesca Felicia Operto, Child Neuropsychiatry Unit, Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari ‘‘Aldo Moro’’, Bari, Italy<break></break>
Email: <email>opertofrancesca@gmail.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>5</month>
<year>2019</year>
</pub-date>
<volume>9</volume>
<issue>5</issue>
<issue-id pub-id-type="doi">10.1002/brb3.2019.9.issue-5</issue-id>
<elocation-id>e01250</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>03</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2019 Published by Wiley Periodicals, Inc. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Brain and Behavior</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BRB3-9-e01250.pdf" xlink:type="simple"></self-uri>
<abstract id="brb31250-abs-0001">
<title>Abstract</title>
<sec id="brb31250-sec-0001">
<title>Introduction</title>
<p>Rett syndrome (RTT) is a severe X‐linked neurodevelopmental disorder that primarily affects girls, with an incidence of 1:10,000–20,000. The diagnosis is based on clinical features: an initial period of apparently normal development (ages 6–12 months) followed by a rapid decline with regression of acquired motor skills, loss of spoken language and purposeful hand use, onset of hand stereotypes, abnormal gait, and growth failure. The course of the disease, in its classical form, is characterized by four stages. Three different atypical variants of the disease have been defined. Epilepsy has been reported in 60%–80% of patients with RTT; it differs among the various phenotypes and genotypes and its severity is an important contributor to the clinical severity of the disease.</p>
</sec>
<sec id="brb31250-sec-0002">
<title>Methods</title>
<p>In this manuscript we reviewed literature on RTT, focusing on the different genetic entities, the correlation genotype–phenotype, and the peculiar epileptic phenotype associated to each of them.</p>
</sec>
<sec id="brb31250-sec-0003">
<title>Results</title>
<p>Mutations in MECP2 gene, located on Xq28, account for 95% of typical RTT cases and 73.2% of atypical RTT. CDKL5 and FOXG1 are other genes identified as causative genes in atypical forms of RTT. In the last few years, a lot of new genes have been identified as causative genes for RTT phenotype.</p>
</sec>
<sec id="brb31250-sec-0004">
<title>Conclusions</title>
<p>Recognizing clinical and EEG patterns in different RTT variants may be useful in diagnosis and management of these patients.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="brb31250-kwd-0001">epilepsy</kwd>
<kwd id="brb31250-kwd-0002">genetic</kwd>
<kwd id="brb31250-kwd-0003">Rett syndrome</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="5"></table-count>
<page-count count="10"></page-count>
<word-count count="7785"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>brb31250</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>May 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:28.06.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="brb31250-cit-1001" publication-type="journal">
<string-name>
<surname>Operto</surname>
<given-names>FF</given-names>
</string-name>, <string-name>
<surname>Mazza</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Pastorino</surname>
<given-names>GMG</given-names>
</string-name>, <string-name>
<surname>Verrotti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>
<given-names>G</given-names>
</string-name>. <article-title>Epilepsy and genetic in Rett syndrome: A review</article-title>. <source xml:lang="en"/>Brain Behav. <year>2019</year>;<volume>9</volume>:<elocation-id>e01250</elocation-id>
<pub-id pub-id-type="doi">10.1002/brb3.1250</pub-id>
<pub-id pub-id-type="pmid">30929312</pub-id></mixed-citation>
</p>
</notes>
</front>
<body>
<sec id="brb31250-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>Rett syndrome (RTT) is a severe X‐linked neurodevelopmental disorder first described in the medical literature more than 50 years ago: in 1966 Dr. Andreas Rett described 22 girls with a progressive neurological syndrome with seizures (Rett, <xref ref-type="ref" rid="brb31250-bib-0052">1966</xref>). Later, in 1983, Hagberg et al. imported the eponym Rett syndrome to 35 girls with similar characteristics, along with the first diagnostic criteria (Hagberg, Aicardi, Dias, &amp; Ramos, <xref ref-type="ref" rid="brb31250-bib-0018">1983</xref>). In 1999, Amir et al. identified the genetic cause of RTT as a loss of function mutation in the gene Methyl‐CpG‐binding protein 2 (MECP2) (Amir et al., <xref ref-type="ref" rid="brb31250-bib-0002">1999</xref>). In 1994, Hagberg and Skjeldal developed more precise diagnostic criteria (Hagberg &amp; Skjeldal, <xref ref-type="ref" rid="brb31250-bib-0019">1994</xref>); since then, clinical spectrum has been better clarified and diagnostic criteria have been modified in the last version of 2010 (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>).</p>
<p>Rett syndrome primarily affects girls, with an incidence of 1:10,000–20,000 (Hagberg, Hanefeld, Percy, &amp; Skjeldal, <xref ref-type="ref" rid="brb31250-bib-0017">2002</xref>). The diagnosis of RTT is based on clinical features, although, in clinical practice, gene analysis is performed to confirm it and to determine the causative mutation. Most children with RTT are the born from a normal pregnancy and delivery (Dolce, Ben‐Zeev, Naidu, &amp; Kossoff, <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>). An initial period of apparently normal development (ages 6–12 months) is followed by a period of rapid decline with regression of acquired motor skills, loss of spoken language and purposeful hand use, onset of hand stereotypes, abnormal gait, and growth failure. This regression is sometimes sudden and often rapid, occurring in the time span of weeks to months and usually this period is associated with severe sleep disturbances, irritability, and poor eye contact (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>). According to revised diagnostic criteria for RTT by Neul et al., in classic RTT, a period of regression followed by recovery or stabilization and the presence of four main criteria and two exclusion criteria are required for diagnosis (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>; Table <xref ref-type="table" rid="brb31250-tbl-0001">1</xref>). With regard to postnatal deceleration in head growth, it is an early sign, which begins between 2 and 4 months of age (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>). Nevertheless, it is not found in all patients with typical RTT (Hagberg, Stenbom, &amp; Witt Engerstrom, <xref ref-type="ref" rid="brb31250-bib-0020">2000</xref>); for this reason, it has been eliminated from the necessary criteria, but it is considered nowadays a preamble to them, as a feature that should raise suspicion for the diagnosis (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>).</p>
<table-wrap id="brb31250-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Revised clinical criteria for Typical RTT (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="4">Main criteria</td>
<td align="left" colspan="1" rowspan="1">1. Partial or complete loss of acquired purposeful hand skills</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2. Partial or complete loss of acquired spoken language</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3. Gait abnormalities: impaired (dyspraxic) or absence of ability</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4. Stereotypic hand movements (hand wringing/squeezing, clapping/tapping, mouthing and washing/rubbing automatisms)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">Exclusion criteria</td>
<td align="left" colspan="1" rowspan="1">1. Brain injury secondary to trauma (peri‐ or postnatally), neurometabolic disease, severe infections that causes neurological problems</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2. Grossly abnormal psychomotor development in first 6 months of life</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>The course of the disease, in its classical form, is characterized by four stages with an apparently normal early psychomotor development in the first 6 months of life (Hagberg et al., <xref ref-type="ref" rid="brb31250-bib-0017">2002</xref>; Table <xref ref-type="table" rid="brb31250-tbl-0002">2</xref>). In some cases, vague symptoms may be present, such as hypotonia, jerkiness, and reduced social interaction. Einspieler et al. carefully assessed videos of 22 Rett cases, examining movements, posture, and behavior during the first 6 months of life. Authors demonstrated an abnormal quality of general movements (100%), tongue protrusion (62%), postural stiffness (58%), asymmetric eye opening and closing (56%), abnormal finger movements (52%), hand stereotypies (42%), bursts of abnormal facial expressions (42%), bizarre smile (32%), tremor (28%), and stereotyped body movements (15%) (Einspieler, Kerr, &amp; Prechtl, <xref ref-type="ref" rid="brb31250-bib-0012">2005</xref>).</p>
<table-wrap id="brb31250-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Clinical stages of typical RTT</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Stage</th>
<th align="left" colspan="1" rowspan="1" valign="top">Age</th>
<th align="left" colspan="1" rowspan="1" valign="top">Clinical features</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">I. EARLY ONSET</td>
<td align="left" colspan="1" rowspan="1">6 months−1 year</td>
<td align="left" colspan="1" rowspan="1">hypotonia, delay in gross motor skills, loss of hand skills/speech, less eye contact, social interaction, and interest in toys</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">II. RAPID DESTRUCTIVE</td>
<td align="left" colspan="1" rowspan="1">1 year−3 years</td>
<td align="left" colspan="1" rowspan="1">autistic features, intellectual disability, hand stereotypes, motor dysfunction, respiratory abnormalities; microcephaly</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">III. PLATEAU</td>
<td align="left" colspan="1" rowspan="1">2 years−10 years</td>
<td align="left" colspan="1" rowspan="1">Seizures, improvement of behavior, eye contact, and hand use</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IV. LATE MOTOR DETERIORATION</td>
<td align="left" colspan="1" rowspan="3">&gt;10 years</td>
<td align="left" colspan="1" rowspan="1">further motor deterioration, spasticity/dystonia, scoliosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IVa</td>
<td align="left" colspan="1" rowspan="1">Loss of the ability to walk</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IVb</td>
<td align="left" colspan="1" rowspan="1">Never ambulant</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In addition to the classical form, it has been recognized that some individuals present with many of the clinical features of RTT but do not have all the features of this condition. These have been termed “variant” or “atypical” RTT: the preserved speech variant (Zappella variant), the congenital variant (Rolando variant), and the early seizure variant (Hanefeld variant). For the diagnosis of atypical or variant RTT, a period of regression followed by recovery or stabilization and at least two of the four main criteria and five of the 11 supportive criteria are needed (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>; Table <xref ref-type="table" rid="brb31250-tbl-0003">3</xref>). According to the data of the United States RTT National History Study, on a sample of 819 patients enrolled, 85.4% met diagnostic criteria for classic RTT and 14.6% for RTT variants (Percy et al., <xref ref-type="ref" rid="brb31250-bib-0049">2010</xref>).</p>
<table-wrap id="brb31250-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Diagnostic criteria for atypical or variant RTT (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="4">Main criteria (2 out of 4)</td>
<td align="left" colspan="1" rowspan="1">1. Partial or complete loss of acquired purposeful hand skills</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2. Partial or complete loss of acquired spoken language</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3. Gait abnormalities: impaired (dyspraxic) or absence of ability</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4. Stereotypic hand movements (hand wringing/squeezing, clapping/tapping, mouthing and washing/rubbing automatisms)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="11">Supportive criteria (5 out of 11)</td>
<td align="left" colspan="1" rowspan="1">1. Breathing disturbances when awake</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2. Bruxism when awake</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3. Impaired sleep pattern</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4. Abnormal muscle tone</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5. Peripheral vasomotor disturbances</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6. Scoliosis/kyphosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7. Growth retardation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8. Small cold hand and feet</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9. Inappropriate laughing/screaming spells</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10. Diminished response to pain</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11. Intense eye communication‐“eye pointing”</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Zappella variant is a clinical variant characterized by regression at 1–3 years, prolonged plateau phase, milder compromission of purposeful hand use, and milder intellectual disability. The distinctive feature of this variant is the recovery of language after regression, at a mean age of 5 years, along with the rarity of epilepsy. MeCP2 gene mutations are found in majority.</p>
<p>Rolando variant (or congenital variant) is characterized by severe psychomotor delay with inability to walk, severe postnatal microcephaly, regression in first 5 months, lack of typical RTT eye gaze, autonomic abnormalities (small cold hands and feet, peripheral vasomotor disturbances, breathing abnormalities while awake), and movement abnormalities (tongue stereotypes, jerky movements of the limbs). Mutations in MECP2 gene are rarely found in this variant, which is closely linked to mutations in FOXG1 (Forkhead box protein G1) gene.</p>
<p>Hanefeld variant is characterized by early onset of seizures (infantile spasms and refractory myoclonic epilepsy) before regression, usually before 5 months of life. Other typical RTT features are less frequent. Also, in this variant, mutations in the MECP2 gene are rarely found, as it is characterized by mutations in the CDKL5 (cyclin‐dependent kinase‐like 5) gene, a regulator of MECP2 which also has important roles in neuronal maturation and brain development.</p>
<p>RTT is the major cause of mental retardation in females after Down syndrome (Krajnc, <xref ref-type="ref" rid="brb31250-bib-0033">2015</xref>), but it has also been documented in normal female carriers, in females with variant forms, and in some males with Klinefelter syndrome, fatal encephalopathy, familial X‐linked mental retardation, and males with features of RTT (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0026">2010</xref>). As an X‐linked disorder, RTT was considered lethal in males; however, males with clinical features of RTT were reported even before the discovery of the causal gene. Wan et al. first described a male patient with a congenital neonatal encephalopathy and mutation in MECP2, who died at 1 year of age (Wan et al., <xref ref-type="ref" rid="brb31250-bib-0067">1999</xref>). Males with MECP2 mutations fall into four categories: severe neonatal encephalopathy and infantile death; classical RTT; less severe neuropsychiatric symptoms; MECP2 duplication syndrome (Imessaoudene et al., <xref ref-type="ref" rid="brb31250-bib-0025">2001</xref>; Jülich, Horn, Burfeind, Erler, &amp; Auber, <xref ref-type="ref" rid="brb31250-bib-0029">2009</xref>; Kyle, Vashi, &amp; Justice, <xref ref-type="ref" rid="brb31250-bib-0034">2018</xref>; Meloni et al., <xref ref-type="ref" rid="brb31250-bib-0041">2000</xref>; Ramocki et al., <xref ref-type="ref" rid="brb31250-bib-0051">2009</xref>; Schwartzman, Bernardino, Nishimura, Gomes, &amp; Zatz, <xref ref-type="ref" rid="brb31250-bib-0059">2001</xref>; Topҫu et al., <xref ref-type="ref" rid="brb31250-bib-0063">2002</xref>; Van Esch et al., <xref ref-type="ref" rid="brb31250-bib-0065">2005</xref>; Zeev et al., <xref ref-type="ref" rid="brb31250-bib-0073">2002</xref>; Table <xref ref-type="table" rid="brb31250-tbl-0004">4</xref>).</p>
<table-wrap id="brb31250-tbl-0004" orientation="portrait" position="float" xml:lang="en">
<label>Table 4</label>
<caption>
<p>Clinical features and genetic profile in males with MECP2 mutations (Kyle et al., <xref ref-type="ref" rid="brb31250-bib-0034">2018</xref>)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top"> </th>
<th align="left" colspan="1" rowspan="1" valign="top">Genetic profile</th>
<th align="left" colspan="1" rowspan="1" valign="top">Clinical features</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1. Severe neonatal encephalopathy and infantile death</td>
<td align="left" colspan="1" rowspan="1">MECP2 mutations inherited from mildly symptomatic or asymptomatic mothers</td>
<td align="left" colspan="1" rowspan="1">If born, severe neonatal encephalopathy with respiratory arrest and seizures and death within 2 years of age</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2. Classical RTT</td>
<td align="left" colspan="1" rowspan="1">XXY karyotype or other somatic mosaicisms</td>
<td align="left" colspan="1" rowspan="1">Like RTT clinical features in female patients</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3. Less severe neuropsychiatric symptoms</td>
<td align="left" colspan="1" rowspan="1">MECP2 mutations less severe than those in female patients</td>
<td align="left" colspan="1" rowspan="1">
Intellectual disability and motor abnormalities (broad spectrum of symptoms and possible overlap with features of Angelman syndrome)
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4. MECP2 duplication syndrome</td>
<td align="left" colspan="1" rowspan="1">Gain of MECP2 dosage</td>
<td align="left" colspan="1" rowspan="1">Hypotonia, severe intellectual disability, lung infections, seizures, absent or limited speech and walking, motor spasticity, and muscle stiffness</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="brb31250-sec-0006">
<label>2</label>
<title>CURRENT UPDATE IN THE GENETIC OF RETT SYNDROME</title>
<p>It is well established that mutations in MECP2 gene, located on Xq28, account for 95% of typical RTT cases and 73.2% of atypical RTT (Ehrhart, Sangani, &amp; Curfs, <xref ref-type="ref" rid="brb31250-bib-0011">2018</xref>). MECP2 is a protein ubiquitously present throughout all human tissues and particularly abundant in neurons and astrocytes in the brain. It is expressed at low levels prenatally and increases during neuronal maturation and synaptogenesis suggesting an important role in neuronal activity and plasticity (Cohen et al., <xref ref-type="ref" rid="brb31250-bib-0008">2003</xref>; Jung et al., <xref ref-type="ref" rid="brb31250-bib-0030">2003</xref>; Samaco, Nagarajan, Braunschweig, &amp; LaSalle, <xref ref-type="ref" rid="brb31250-bib-0057">2004</xref>). The exact mechanism by which loss of MECP2 results in the distinctive clinical features of RTT remains uncertain; it is supposed that abnormal cortical glutamatergic synaptic responses and excitatory connectivity result in excess of inhibition and deficits in neuronal plasticity (<xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>). MECP2 mutations usually occur de novo: in &gt;99% of cases these mutations occur sporadically, in less than 1% are inherited from one parent (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>); familial cases originate from mutations inherited from healthy or mildly affected mothers or from gonadal mosaicism (Matijevic, Knezevic, Slavica, &amp; Pavelic, <xref ref-type="ref" rid="brb31250-bib-0039">2009</xref>). Majority of patients is therefore heterozygous for MECP2 mutation, carrying one normal and one mutated copy of the gene (Kyle et al., <xref ref-type="ref" rid="brb31250-bib-0034">2018</xref>; Neul et al., <xref ref-type="ref" rid="brb31250-bib-0044">2008</xref>). Most of the de novo mutations occur almost exclusively in the paternal gamete (Trappe et al., <xref ref-type="ref" rid="brb31250-bib-0064">2001</xref>). Currently, about 800 different mutations of MECP2 gene causing RTT have been identified: point mutations, insertions, duplications, small or large deletions in almost all parts of the gene (Ehrhart et al., <xref ref-type="ref" rid="brb31250-bib-0011">2018</xref>). Majority of causative mutations has been found in eight single‐nucleotide polymorphism hotspots as missense and nonsense mutations: T158M; R255X; R168X; R306C; R294X; R270X; R133C (Kyle et al., <xref ref-type="ref" rid="brb31250-bib-0034">2018</xref>; Percy et al., <xref ref-type="ref" rid="brb31250-bib-0049">2010</xref>). These mutations account for approximately 70% of all mutations (Kyle et al., <xref ref-type="ref" rid="brb31250-bib-0034">2018</xref>) and R168X is the most common one; C‐terminal deletions account for 8% and large deletions for another 5% (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0044">2008</xref>).</p>
<p>Despite the wide spectrum of MECP2 mutations and the variety of phenotype severity, there are no clear genotype–phenotype correlations (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>). Some studies in literature have proposed a correlation between genotype and clinical features in RTT patients (Cuddapah et al., <xref ref-type="ref" rid="brb31250-bib-0009">2014</xref>; Neul et al., <xref ref-type="ref" rid="brb31250-bib-0044">2008</xref>). Early truncating mutations such as R168X, R255X, and R270X and large insertions and deletions cause the most severe phenotype. Missense mutations such as R133C and R306C, late truncating mutations such as those in R294X and others in the 3’ end are associated with the mildest phenotype. Despite this, phenotype variations commonly occur between patients with the same mutation. Some possible explanation has been proposed, as differences in X chromosome inactivation (Ehrhart et al., <xref ref-type="ref" rid="brb31250-bib-0011">2018</xref>; Knudsen et al., <xref ref-type="ref" rid="brb31250-bib-0031">2006</xref>) and the presence of a second gene mutation, acting as modifier, alleviating or enhancing the phenotype outcome (Zeev et al., <xref ref-type="ref" rid="brb31250-bib-0073">2002</xref>).</p>
<p>RTT was diagnosed also in 3%–5% patients who were negative for MECP2 mutations (Neul et al., <xref ref-type="ref" rid="brb31250-bib-0044">2008</xref>). CDKL5 and FOXG1 are other genes identified as causative genes in atypical forms of RTT, respectively the Hanefeld Variant and Rolando variant (Ariani et al., <xref ref-type="ref" rid="brb31250-bib-0003">2008</xref>; Weaving et al., <xref ref-type="ref" rid="brb31250-bib-0068">2004</xref>).</p>
<p>CDKL5 is a gene located on Xp22 and code for a ubiquitous protein, mainly expressed in the brain, thymus, and testes, with a role in neuronal maturation (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>; Rusconi et al., <xref ref-type="ref" rid="brb31250-bib-0053">2008</xref>). Several mutations in the CDKL5 gene have been identified: point mutations, sequence variations resulting in missense, nonsense, splice and frameshift mutations, microdeletions, and larger rearrangements (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>). CDKL5 is involved in the early seizure variant of RTT (Mari et al., <xref ref-type="ref" rid="brb31250-bib-0038">2005</xref>; Scala et al., <xref ref-type="ref" rid="brb31250-bib-0058">2005</xref>).</p>
<p>FOXG1 is a transcriptional repressor involved in neuronal differentiation and highly expressed in the developing brain, whose gene is located on chromosome 14q12. Mutations in FOXG1 are responsible for the congenital variant of RTT (Ariani et al., <xref ref-type="ref" rid="brb31250-bib-0003">2008</xref>). Patients with FOXG1 mutations (duplications/deletions, nonsense, frameshift and missense mutations) have clinical features characterized by postnatal growth deficiency and microcephaly, developmental delay with absent speech, defective social reciprocity, poor sleep, stereotypes, dyskinesia, and severe early onset epilepsy (Brunetti‐Pierri et al., <xref ref-type="ref" rid="brb31250-bib-0006">2011</xref>; Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>; Yeung et al., <xref ref-type="ref" rid="brb31250-bib-0069">2009</xref>).</p>
<p>In the last few years, using whole exome sequencing, many other uncommon genetic mutations in 69 new genes have been identified as causative for RTT phenotype (classic or variant) (Ehrhart et al., <xref ref-type="ref" rid="brb31250-bib-0011">2018</xref>; Table <xref ref-type="table" rid="brb31250-tbl-0005">5</xref>).</p>
<table-wrap id="brb31250-tbl-0005" orientation="portrait" position="float" xml:lang="en">
<label>Table 5</label>
<caption>
<p>New causative genes identified in the last few years as causative genes for RTT phenotype (review of recent literature)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">SMC1A</td>
<td align="left" colspan="1" rowspan="1">Glissen et al. (<xref ref-type="ref" rid="brb31250-bib-0013">2014</xref>), Huisman et al. (<xref ref-type="ref" rid="brb31250-bib-0024">2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TBL1XR1</td>
<td align="left" colspan="1" rowspan="1">Saitsu et al. (<xref ref-type="ref" rid="brb31250-bib-0055">2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GABRD</td>
<td align="left" colspan="1" rowspan="1">Okamoto et al. (<xref ref-type="ref" rid="brb31250-bib-0046">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCN2A</td>
<td align="left" colspan="1" rowspan="1">Baasch et al. (<xref ref-type="ref" rid="brb31250-bib-0004">2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SHANK3</td>
<td align="left" colspan="1" rowspan="1">Hara et al. (<xref ref-type="ref" rid="brb31250-bib-0021">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCN8A, IQSEC2</td>
<td align="left" colspan="1" rowspan="1">Olson et al. (<xref ref-type="ref" rid="brb31250-bib-0047">2015</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">WDR45</td>
<td align="left" colspan="1" rowspan="1">Hoffjan et al. (<xref ref-type="ref" rid="brb31250-bib-0023">2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">JMJD1C</td>
<td align="left" colspan="1" rowspan="1">Saez et al. (<xref ref-type="ref" rid="brb31250-bib-0054">2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SATB2</td>
<td align="left" colspan="1" rowspan="1">Lee et al. (<xref ref-type="ref" rid="brb31250-bib-0035">2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GABBR2</td>
<td align="left" colspan="1" rowspan="1">Yoo et al. (<xref ref-type="ref" rid="brb31250-bib-0070">2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IQSEC2, KCNA2</td>
<td align="left" colspan="1" rowspan="1">Allou et al. (<xref ref-type="ref" rid="brb31250-bib-0001">2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ANKRD31, CHRNA5, HCN1, SCN1A, TCF4, GRIN2B, SLC6A1, MGRN1, BTBD9, SEMA6B, AGAP6, MGRN1, VASH2, ZNF620, GRAMD1A, GABBR2, ATP8B1, HAP1, PDLIM7, SRRM3, CACNA1I</td>
<td align="left" colspan="1" rowspan="1">Lucariello et al. (<xref ref-type="ref" rid="brb31250-bib-0037">2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TCF4, EEF1A2, STXBP1, ZNF238, SLC35A2, ZFX, SHROOM4, EIF2B2, RHOBTB2, SMARCA1, GABBR2, EIF4G1, HTT</td>
<td align="left" colspan="1" rowspan="1">Lopes et al. (<xref ref-type="ref" rid="brb31250-bib-0036">2016</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PWP2, SCG2, IZUMO4, XAB2, ZSCAN12, IQSEC2, FAM151A, SYNE2, SMC1A, ARHGEF10L, HDAC1, TAF1B, KCNJ10, CHD4, LRRC40, LAMB2, GRIN2B, IMPDH2, SAFB2, ACTL6B, STXBP1, TRRAP, WDR45, SLC39A13, FAT13, IQGAP3, NCOR2, GABRB2, TCF4, GRIN2A</td>
<td align="left" colspan="1" rowspan="1">Sajan et al. (<xref ref-type="ref" rid="brb31250-bib-0056">2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GRIN2B, GABBR2, MEF2C, STXBP1, KCNQ2, SLC2A1, TCF4, SCN2A, SYNGAP1, CACNA1I, CHRNA5, HCN1</td>
<td align="left" colspan="1" rowspan="1">Vidal et al. (<xref ref-type="ref" rid="brb31250-bib-0066">2017</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">STXBP1</td>
<td align="left" colspan="1" rowspan="1">Yuge et al. (<xref ref-type="ref" rid="brb31250-bib-0071">2018</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CTNNB1, WDR45</td>
<td align="left" colspan="1" rowspan="1">Percy et al. (<xref ref-type="ref" rid="brb31250-bib-0048">2018</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SCNA1</td>
<td align="left" colspan="1" rowspan="1">Henriksen, Ravn, Paus, Tetzchner, and Skjeldal (<xref ref-type="ref" rid="brb31250-bib-0022">2018</xref>)</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>In classical or atypical clinical variants of RTT, a PCR‐mutation screening of exons 3 and 4 of MECP2 gene should be first performed and, in the case of negativity, further screening for large deletions or small MECP2 mutations in exons 1 and 2 should be carried on.</p>
<p>In case of suspected early onset Rett syndrome, with epileptic seizures or spasms or microcephaly even in males, CDKL5 mutation screening and FOXG1 should follow.</p>
<p>In case of negativity, targeted resequencing consisting of ad hoc gene panels or whole exome sequency should then be recommended, together with an array CGH analysis to exclude microdeletions/microduplications on the whole chromosomal set. The high banding karyotype may have priority in males with Rett‐like phenotype and possible XXY aneuploidy.</p>
</sec>
<sec id="brb31250-sec-0007">
<label>3</label>
<title>EPILEPSY IN RETT SYNDROME</title>
<p>Epilepsy has been reported in 60%–80% of patients with RTT, differing among the various phenotypes and genotypes. Incidence is higher in patients with early onset RTT and more severe developmental disabilities (greater impairment of ambulation, hand use, and communication) (Glaze et al., <xref ref-type="ref" rid="brb31250-bib-0014">2010</xref>). On the other hand, the severity of epilepsy is an important contributor to the clinical severity of RTT phenotype (Krajnc, <xref ref-type="ref" rid="brb31250-bib-0033">2015</xref>). Seizures seem to occur earlier in those patients who do not have MECP2 mutations (Jian et al., <xref ref-type="ref" rid="brb31250-bib-0027">2006</xref>).</p>
<p>There is not a characteristic “first seizure” semiology in Rett syndrome (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>) and all seizure types have been reported (Krajnc, <xref ref-type="ref" rid="brb31250-bib-0033">2015</xref>). Complex partial and generalized tonic‐clonic are the commonest seizure types in RTT (Pintaudi et al., <xref ref-type="ref" rid="brb31250-bib-0050">2010</xref>), whereas absence and clonic seizures are less frequent (Buoni et al., <xref ref-type="ref" rid="brb31250-bib-0007">2008</xref>; Steffenburg, Hagberg, &amp; Hagberg, <xref ref-type="ref" rid="brb31250-bib-0060">2001</xref>). Moreover, also early febrile seizures seem to be more frequent in RTT compared with general population (12% vs. 2%–5%) (Nissenkorn et al., <xref ref-type="ref" rid="brb31250-bib-0045">2010</xref>).</p>
<p>Steffenburg et al. have suggested that early onset of seizures can be associated with more seizure types, intractable epilepsy, and status epilepticus (Steffenburg et al., <xref ref-type="ref" rid="brb31250-bib-0060">2001</xref>), whereas Nissenkorn et al. stated that seizure onset after 5 years is a good prognostic factor (Nissenkorn et al., <xref ref-type="ref" rid="brb31250-bib-0045">2010</xref>). Reviewing literature, beyond the age of onset, other factors have been identified as risk factors for epilepsy and its severity: microcephaly (Steffenburg et al., <xref ref-type="ref" rid="brb31250-bib-0060">2001</xref>), developmental delay in the first 10 months of life, and absence of walking (Jian et al., <xref ref-type="ref" rid="brb31250-bib-0027">2006</xref>), certain mutations in the MECP2 gene with regard to classical form (Glaze et al., <xref ref-type="ref" rid="brb31250-bib-0014">2010</xref>).</p>
<p>Despite its frequent presence in Rett syndrome, epilepsy can be difficult to diagnose as many other clinical manifestations could be mistaken as seizures. According to Guerrini et al., the overall occurrence of epilepsy in Rett syndrome is probably overestimated and in their sample of 389 patients, only 48% could be considered as having true epileptic seizures (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>). Glaze et found that, among parent‐reported seizure behaviors, only one third was temporally associated with epileptiform abnormalities on electroencephalogram (EEG) (Glaze et al., <xref ref-type="ref" rid="brb31250-bib-0014">2010</xref>). In RTT patients, several behaviors could be wrongly classified as epileptic seizures: hand stereotypies, breath‐holding and cyanosis, hyperventilation and chaotic breathing pattern in the waking state, staring, oculogyric movements, blinking episodes, oral facial dyskinesias, bouts of laughing or screaming, tremor, dystonia, jerking, spasticity, and episodic atonia. Obviously, a misdiagnosis can lead to patient's overtreatment and even pseudo drug‐resistance.</p>
<p>EEG is an important diagnostic tool because it allows to distinguish true seizures from nonepileptic events. However, it is important to consider that EEG can be abnormal in Rett syndrome, even without the presence of epilepsy in comorbidity; in such cases a prolonged video EEG could help clinicians (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>).</p>
<p>According to Tarquinio et al., because EEG is almost universally abnormal after age 3 in Rett syndrome, clinicians should not prescribe antiseizure medications for patients without clear epileptic seizures, despite an abnormal EEG (Tarquinio et al., <xref ref-type="ref" rid="brb31250-bib-0062">2017</xref>).</p>
<sec id="brb31250-sec-0008">
<label>3.1</label>
<title>Epilepsy on MECP2‐positive patients</title>
<p>With regard to classical form, seizures usually appear in the II or III stage of the disease, with the highest frequency occurring between 7 and 12 years (Krajnc, <xref ref-type="ref" rid="brb31250-bib-0033">2015</xref>).</p>
<p>Reviewing literature, severe mutations in MECP2 gene, such as large deletions, early truncating, and missense mutations in the methyl‐binding domain or the nuclear localizing segment seem to be associated with earlier or more sever epilepsy, whereas milder mutations such as late truncating or C‐terminal deletions seem to have a protective effect on epilepsy onset (Jian et al., <xref ref-type="ref" rid="brb31250-bib-0027">2006</xref>, <xref ref-type="ref" rid="brb31250-bib-0028">2007</xref>; Nectoux et al., <xref ref-type="ref" rid="brb31250-bib-0043">2008</xref>; Pintaudi et al., <xref ref-type="ref" rid="brb31250-bib-0050">2010</xref>).</p>
<p>Jian et al., in 2006, investigated risk factors for seizure onset in Rett syndrome in a sample of 288 patients. They found that R168X, R294X, and C‐terminal mutations in MECP2 gene, conferred a protective factor for seizure onset before 4 years of age, whereas X inactivation seemed to be a protective factor against seizure onset before 48 months of life. Authors also found that, among MECP2 mutations, the median age of seizure onset varied from 37 months in those patients with R255X mutation to 76 months in those with R294X (Jian et al., <xref ref-type="ref" rid="brb31250-bib-0027">2006</xref>).</p>
<p>Pintaudi et al. found that epilepsy was more frequent in patients with large MECP2 deletions and R294X mutation and it occurred less frequently in subjects with no identified mutations and C‐terminal deletions in MECP2. The latter proved to be a protective factor, with respect to both the occurrence of epilepsy and drug resistance. Moreover, patients with large MECP2 deletions started having seizure later (6.72 years), rather than those patients with other types of mutations, particularly R168X and R255X (Pintaudi et al., <xref ref-type="ref" rid="brb31250-bib-0050">2010</xref>).</p>
<p>In 2012, Guerrini et al. examined 389 patients with RTT, including 315 classical and 74 atypical Rett patients. Authors found that occurrence of seizures was comparable in the two groups (60% vs. 61%), with MECP2 identified in 90% of patients (93% of the classical Rett subgroup) and seizures reported in 59% of those patients with MECP2 mutations and in 73% of those without MECP2 mutations. In the first subgroup, 60% of patients had a mutation in one of the eight most common mutations (R106W, R133C, T158M, R168X, R255X, R270X, R294X, R160C), 9% had C‐terminal deletions and 8,5% had large deletions. Among all, seizures were more frequent in patients with T158M mutation (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>). This finding is consistent with a previous one by Glaze et al., who found significantly more epilepsy in patients with T158 mutation and R106W, than subjects with R255X or R306C mutations (Glaze et al., <xref ref-type="ref" rid="brb31250-bib-0014">2010</xref>). Furthermore, Buoni et al. had formerly reported a higher prevalence of the T158 mutation in drug‐resistant epilepsy (Buoni et al., <xref ref-type="ref" rid="brb31250-bib-0007">2008</xref>).</p>
</sec>
<sec id="brb31250-sec-0009">
<label>3.2</label>
<title>Epilepsy on CDKL5‐positive patients</title>
<p>The early seizure variant (Hanefeld variant), associated with CDKL5 mutations, is characterized by seizure onset before 5 months of age, usually with infantile spasms (50%) and refractory myoclonic epilepsy (25%) (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>; Pintaudi et al., <xref ref-type="ref" rid="brb31250-bib-0050">2010</xref>).</p>
<p>In RTT associated with CDKL5 mutations, epilepsy is typically manifested as an epileptic encephalopathy, with infantile spasm, multifocal and myoclonic seizures. Bahi‐Buisson et al. have described a three‐step epilepsy phenotype associated with CDKL5 mutations in 13 girls aged from 2.5 to 19 years: early epilepsy (stage I), then epileptic encephalopathy (stage II) and finally, late multifocal and myoclonic epilepsy (stage III). Moreover, according to the Authors, patients with mutations involving the catalytic domain of the protein show earlier onset and intractable infantile spasms and more severe late onset multifocal and myoclonic epilepsy than patients with truncating mutations downstream of the catalytic domain (Bahi‐Buisson et al., <xref ref-type="ref" rid="brb31250-bib-0005">2008</xref>).</p>
</sec>
<sec id="brb31250-sec-0010">
<label>3.3</label>
<title>Epilepsy on FOXG1‐positive patients</title>
<p>Severe early onset epilepsy has been reported as main features of the FOXG1‐related phenotype (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>). Kortüm et al. have described 11 patients carrying mutations in FOXG1 gene documenting tonic, generalized tonic‐clonic and partial seizures, with onset between 3 months and 6 years (Kortüm et al., <xref ref-type="ref" rid="brb31250-bib-0032">2011</xref>). Moreover, the association between 14q12 duplication including FOXG1 and infantile spasms has been documented (Striano et al., <xref ref-type="ref" rid="brb31250-bib-0061">2011</xref>), suggesting that overexpression of FOXG1 could have a specific role in the pathogenesis of infantile spasms.</p>
</sec>
</sec>
<sec id="brb31250-sec-0011">
<label>4</label>
<title>EEG FINDINGS</title>
<p>In literature, there are few reports of the characteristics EEG findings in patients with Rett syndrome, especially with regard to atypical variants (Figure <xref ref-type="fig" rid="brb31250-fig-0001">1</xref>).</p>
<fig fig-type="Figure" id="brb31250-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>EEG pattern of (a) a classical Rett syndrome, (b) a child with FOXG1 microduplication and epileptic spasms and microcephaly, (c) a 4‐month CDKL5 girl with tonic/vibratory seizure followed by a cluster of spasms and clonic jerks</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="BRB3-9-e01250-g001"></graphic>
</fig>
<sec id="brb31250-sec-0012">
<label>4.1</label>
<title>EEG on MECP2‐positive patients</title>
<p>In classical form, EEG pattern progress through the four clinical stages of the disease, however with abnormalities that are not diagnostic for Rett syndrome. Very early in the disease, in Stage 1, seizures are not a prominent feature and EEGs typically tend to be normal. In Stage 2, focal spikes in the centrotemporal regions may be seen, with a characteristic involvement of the motor cortex that correlates with the clinical onset of motor abnormalities; progressively, sleep abnormalities appear. Seizure burden is prominent in Stage 3; in this stage, EEG is characterized by abnormal sleep patterns, bilaterally synchronous bursts of pseudoperiodic delta activity, and generalized rhythmic spike discharges. In stage 4, seizures are no longer a prominent feature; EEGs show slowing of background activity, theta activity in central and frontal regions, multifocal epileptiform activity in awake state, and generalized slow spike‐wave activity in sleep (Dolce et al., <xref ref-type="ref" rid="brb31250-bib-0010">2013</xref>; Moser, Weber, &amp; Lutschg, <xref ref-type="ref" rid="brb31250-bib-0042">2007</xref>).</p>
<p>EEG findings that have been described as correlate of these ictal events are bilateral and synchronous initial flattening, followed by repetitive sharp waves and spikes; generalized ictal patterns in neonates or very young infants, atypical hypsarrhythmia, slowing background with multifocal interictal discharges, and suppression burst pattern (Grosso et al., <xref ref-type="ref" rid="brb31250-bib-0015">2007</xref>; Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>; Melani et al., <xref ref-type="ref" rid="brb31250-bib-0040">2011</xref>).</p>
</sec>
<sec id="brb31250-sec-0013">
<label>4.2</label>
<title>EEG on CDKL5‐positive patients</title>
<p>Limited information is available regarding the precise electroclinical phenotype in epileptic patients with mutations in CDKL5 gene. Bahi‐Buisson et al. have reported the electroclinical description of epilepsy in 12 patients with pathogenetic CDKL5 mutations. Authors found that early EEG showed generalized flattening of the tracing with a fast activity discharge followed by spikes and waves in both frontal and central regions in stage I; stage II EEG was characterized by modified hypsarrhythmia or very slow activity consisting of bilateral high‐amplitude delta waves, intermixed with spikes and polyspikes on both frontal, central, or occipital regions; during stage III, myoclonic seizures were associated with isolated polyspikes and wave complex or with fast activity on both central regions, whereas interictal EEG showed high‐amplitude spikes, polyspikes, and waves in central, temporal, or temporooccipital regions (Bahi‐Buisson et al., <xref ref-type="ref" rid="brb31250-bib-0005">2008</xref>).</p>
</sec>
<sec id="brb31250-sec-0014">
<label>4.3</label>
<title>EEG on FOXG1‐positive patients</title>
<p>To our knowledge, there are few reports concerning EEG findings in patients with RTT phenotype associated with FOXG1 mutations. Available EEG data only report focal and multifocal abnormalities in patients with tonic, generalized tonic‐clonic and complex partial seizures (Guerrini et al., <xref ref-type="ref" rid="brb31250-bib-0016">2012</xref>; Kortüm et al., <xref ref-type="ref" rid="brb31250-bib-0032">2011</xref>).</p>
</sec>
</sec>
<sec id="brb31250-sec-0015">
<label>5</label>
<title>CONCLUSIONS</title>
<p>Rett syndrome is a truly complex neurological disorder, whose diagnostic criteria are based on phenotypic description. In addition to the classical form, a heterogeneous spectrum of phenotypes identifies those forms called “atypical Rett”. Nowadays, it seems more correct to consider this broad spectrum of neurological disorders as the expression of a complex encephalopathy. Many efforts have been made to understand the molecular bases that underlie all different clinical phenotypes of RTT. With the increase of knowledge, especially thanks to recent genetic advances, many new genes have been identified as causative for RTT phenotype, in addition to MECP2, CDKL5, and FOXG1.</p>
<p>Epilepsy is a prominent symptom in RTT and it substantially contributes to the severity of the disease. Some genotypes are reported to be more frequently associated with epilepsy and even with a drug‐resistant course. Recognizing clinical and EEG patterns in different RTT variants may be useful in diagnosis and management of these patients. Long‐term video EEG is surely a useful diagnostic tool which allows to differentiate between nonepileptic paroxysmal events and real epileptic seizures, to further classify seizure semiology and finally choice the most appropriate drug treatment. On the other hand, the identification of individual genetic background allows to diagnose the disorder properly and is helpful for treatment, not only for the genetic counseling.</p>
<p>In this manuscript, we aimed to clear‐up the long‐standing misunderstanding of differential diagnosis between Rett syndrome associated with MECP2 mutations and Rett‐like phenotype of other neurodevelopmental diseases associated with different emerging genes.</p>
<p>Comparative studies with large cohorts of patients are needed to better understand the relationship between genotype and phenotype and correctly diagnose and treat these patients.</p>
</sec>
<sec id="brb31250-sec-0016" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>None.</p>
</sec>
</body>
<back>
<ref-list content-type="cited-references" id="brb31250-bibl-0001">
<title>REFERENCES</title>
<ref id="brb31250-bib-0001">
<mixed-citation id="brb31250-cit-0001" publication-type="journal">
<string-name>
<surname>Allou</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Julia</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Amsallem</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>El Chehadeh</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Lambert</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Thevenon</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Philippe</surname>, <given-names>C.</given-names>
</string-name> (<year>2017</year>). <article-title>Rett‐like phenotypes: Expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5‐related disease</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>91</volume>, <fpage>431</fpage>–<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12784</pub-id>
<pub-id pub-id-type="pmid">27062609</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0002">
<mixed-citation id="brb31250-cit-0002" publication-type="journal">
<string-name>
<surname>Amir</surname>, <given-names>R. E.</given-names>
</string-name>, <string-name>
<surname>Van den Veyver</surname>, <given-names>I. B.</given-names>
</string-name>, <string-name>
<surname>Wan</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Tran</surname>, <given-names>C. Q.</given-names>
</string-name>, <string-name>
<surname>Francke</surname>, <given-names>U.</given-names>
</string-name>, &amp; <string-name>
<surname>Zoghbi</surname>, <given-names>H. Y.</given-names>
</string-name> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X‐linked MECP2, encoding methyl‐CpG‐binding protein 2</article-title>. <source xml:lang="en"/>Nature Genetics, <volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0003">
<mixed-citation id="brb31250-cit-0003" publication-type="journal">
<string-name>
<surname>Ariani</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Hayek</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Rondinella</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Artuso</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Mencarelli</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Spanhol‐Rosseto</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Renieri</surname>, <given-names>A.</given-names>
</string-name> (<year>2008</year>). <article-title>FOXG1 is responsible for the congenital variant of Rett syndrome</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>83</volume>, <fpage>89</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.05.015</pub-id>
<pub-id pub-id-type="pmid">18571142</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0004">
<mixed-citation id="brb31250-cit-0004" publication-type="journal">
<string-name>
<surname>Baasch</surname>, <given-names>A.‐L.</given-names>
</string-name>, <string-name>
<surname>Hüning</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Gilissen</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Klepper</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Veltman</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Gillessen‐Kaesbach</surname>, <given-names>G.</given-names>
</string-name>, … <string-name>
<surname>Lohmann</surname>, <given-names>K.</given-names>
</string-name> (<year>2014</year>). <article-title>Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities</article-title>. <source xml:lang="en"/>Epilepsia, <volume>55</volume>, <fpage>25</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12554</pub-id>
</mixed-citation>
</ref>
<ref id="brb31250-bib-0005">
<mixed-citation id="brb31250-cit-0005" publication-type="journal">
<string-name>
<surname>Bahi‐Buisson</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Kaminska</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Boddaert</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Rio</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Afenjar</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gérard</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Bienvenu</surname>, <given-names>T.</given-names>
</string-name> (<year>2008</year>). <article-title>The three stages of epilepsy in patients with CDKL5 mutations</article-title>. <source xml:lang="en"/>Epilepsia, <volume>49</volume>(<issue>6</issue>), <fpage>1027</fpage>–<lpage>1037</lpage>.<pub-id pub-id-type="pmid">18266744</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0006">
<mixed-citation id="brb31250-cit-0006" publication-type="journal">
<string-name>
<surname>Brunetti‐Pierri</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Paciorkowski</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<surname>Ciccone</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Mina</surname>, <given-names>E. D.</given-names>
</string-name>, <string-name>
<surname>Bonaglia</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Borgatti</surname>, <given-names>R.</given-names>
</string-name>, … <string-name>
<surname>Stankiewicz</surname>, <given-names>P.</given-names>
</string-name> (<year>2011</year>). <article-title>Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment</article-title>. <source xml:lang="en"/>European Journal of Human Genetics, <volume>19</volume>, <fpage>102</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2010.142</pub-id>
<pub-id pub-id-type="pmid">20736978</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0007">
<mixed-citation id="brb31250-cit-0007" publication-type="journal">
<string-name>
<surname>Buoni</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Zannolli</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Felice</surname>, <given-names>C. D.</given-names>
</string-name>, <string-name>
<surname>Saponari</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Strambi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Dotti</surname>, <given-names>M. T.</given-names>
</string-name>, … <string-name>
<surname>Hayek</surname>, <given-names>J.</given-names>
</string-name> (<year>2008</year>). <article-title>Drug‐resistant epilepsy and epileptic phenotype‐EEG association in MECP2 mutated Rett syndrome</article-title>. <source xml:lang="en"/>Clinical Neurophysiology, <volume>119</volume>, <fpage>2455</fpage>–<lpage>2458</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinph.2008.08.015</pub-id>
<pub-id pub-id-type="pmid">18842453</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0008">
<mixed-citation id="brb31250-cit-0008" publication-type="journal">
<string-name>
<surname>Cohen</surname>, <given-names>D. R. S.</given-names>
</string-name>, <string-name>
<surname>Matarazzo</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Tu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>, <given-names>O. H.</given-names>
</string-name>, <string-name>
<surname>Pevsenr</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Ronnet</surname>, <given-names>G. V.</given-names>
</string-name> (<year>2003</year>). <article-title>Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis</article-title>. <source xml:lang="en"/>Molecular and Cellular Neuroscience, <volume>22</volume>, <fpage>417</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1016/S1044-7431(03)00026-5</pub-id>
<pub-id pub-id-type="pmid">12727440</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0009">
<mixed-citation id="brb31250-cit-0009" publication-type="journal">
<string-name>
<surname>Cuddapah</surname>, <given-names>V. A.</given-names>
</string-name>, <string-name>
<surname>Pillai</surname>, <given-names>R. B.</given-names>
</string-name>, <string-name>
<surname>Shekar</surname>, <given-names>K. V.</given-names>
</string-name>, <string-name>
<surname>Lane</surname>, <given-names>J. B.</given-names>
</string-name>, <string-name>
<surname>Motil</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>S. A.</given-names>
</string-name>, … <string-name>
<surname>Olsen</surname>, <given-names>M. L.</given-names>
</string-name> (<year>2014</year>). <article-title>Methyl‐CpG‐binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>51</volume>, <fpage>152</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2013-102113</pub-id>
<pub-id pub-id-type="pmid">24399845</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0010">
<mixed-citation id="brb31250-cit-0010" publication-type="journal">
<string-name>
<surname>Dolce</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Ben‐Zeev</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Naidu</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Kossoff</surname>, <given-names>E. H.</given-names>
</string-name> (<year>2013</year>). <article-title>Rett syndrome and epilepsy: An update for child neurologists</article-title>. <source xml:lang="en"/>Pediatric Neurology, <volume>48</volume>, <fpage>337</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2012.11.001</pub-id>
<pub-id pub-id-type="pmid">23583050</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0011">
<mixed-citation id="brb31250-cit-0011" publication-type="journal">
<string-name>
<surname>Ehrhart</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Sangani</surname>, <given-names>N. B.</given-names>
</string-name>, &amp; <string-name>
<surname>Curfs</surname>, <given-names>L. M. G.</given-names>
</string-name> (<year>2018</year>). <article-title>Current developments in the genetics of Rett and Rett‐like syndrome</article-title>. <source xml:lang="en"/>Current Opinion in Psychiatry, <volume>31</volume>(<issue>2</issue>), <fpage>103</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1097/YCO.0000000000000389</pub-id>
<pub-id pub-id-type="pmid">29206688</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0012">
<mixed-citation id="brb31250-cit-0012" publication-type="journal">
<string-name>
<surname>Einspieler</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Kerr</surname>, <given-names>A. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Prechtl</surname>, <given-names>H. F. R.</given-names>
</string-name> (<year>2005</year>). <article-title>Is the early development of girls with Rett disorder really normal?</article-title>
<source xml:lang="en"/>Pediatric Research, <volume>57</volume>(<issue>5 Pt 1</issue>), <fpage>696</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1203/01.PDR.0000155945.94249.0A</pub-id>
<pub-id pub-id-type="pmid">15718369</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0013">
<mixed-citation id="brb31250-cit-0013" publication-type="journal">
<string-name>
<surname>Gilissen</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Hehir‐Kwa</surname>, <given-names>J. Y.</given-names>
</string-name>, <string-name>
<surname>Thung</surname>, <given-names>D. T.</given-names>
</string-name>, <string-name>
<surname>van de Vorst</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>van Bon</surname>, <given-names>B. W. M.</given-names>
</string-name>, <string-name>
<surname>Willemsen</surname>, <given-names>M. H.</given-names>
</string-name>, … <string-name>
<surname>Veltman</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2014</year>). <article-title>Genome sequencing identifies major causes of severe intellectual disability</article-title>. <source xml:lang="en"/>Nature, <volume>511</volume>, <fpage>344</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1038/nature13394</pub-id>
<pub-id pub-id-type="pmid">24896178</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0014">
<mixed-citation id="brb31250-cit-0014" publication-type="journal">
<string-name>
<surname>Glaze</surname>, <given-names>D. g.</given-names>
</string-name>, <string-name>
<surname>Percy</surname>, <given-names>A. k.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Motil</surname>, <given-names>K. j.</given-names>
</string-name>, <string-name>
<surname>Neul</surname>, <given-names>J. l.</given-names>
</string-name>, <string-name>
<surname>Barrish</surname>, <given-names>J. o.</given-names>
</string-name>, … <string-name>
<surname>Lee</surname>, <given-names>H.‐s.</given-names>
</string-name> (<year>2010</year>). <article-title>Epilepsy and the natural history of Rett syndrome</article-title>. <source xml:lang="en"/>Neurology, <volume>74</volume>, <fpage>809</fpage>–<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181d6b852</pub-id>
</mixed-citation>
</ref>
<ref id="brb31250-bib-0015">
<mixed-citation id="brb31250-cit-0015" publication-type="journal">
<string-name>
<surname>Grosso</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Brogna</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bazzotti</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Renieri</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Morgese</surname>, <given-names>G.</given-names>
</string-name>, &amp; <string-name>
<surname>Balestri</surname>, <given-names>P.</given-names>
</string-name> (<year>2007</year>). <article-title>Seizures and electroencephalographic findings in CDKL5 mutations: Case report and review</article-title>. <source xml:lang="en"/>Brain &amp; Development, <volume>29</volume>, <fpage>239</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2006.09.001</pub-id>
<pub-id pub-id-type="pmid">17049193</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0016">
<mixed-citation id="brb31250-cit-0016" publication-type="journal">
<string-name>
<surname>Guerrini</surname>, <given-names>R.</given-names>
</string-name>, &amp; <string-name>
<surname>Parrini</surname>, <given-names>E.</given-names>
</string-name> (<year>2012</year>). <article-title>Epilepsy in Rett syndrome, and CDKL5‐ and FOXG1‐gene‐related encephalopathies</article-title>. <source xml:lang="en"/>Epilepsia, <volume>53</volume>(<issue>12</issue>), <fpage>2067</fpage>–<lpage>2078</lpage>.<pub-id pub-id-type="pmid">22998673</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0017">
<mixed-citation id="brb31250-cit-0017" publication-type="journal">
<string-name>
<surname>Hagberg</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Hanefeld</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Percy</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Skjeldal</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
</string-name>(<year>2002</year>). <article-title>An update on clinically applicable diagnostic criteria in Rett syndrome</article-title>. <source xml:lang="en"/>European Journal of Paediatric Neurology, <volume>6</volume>(<issue>5</issue>), <fpage>293</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1053/ejpn.2002.0612</pub-id>
<pub-id pub-id-type="pmid">12378695</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0018">
<mixed-citation id="brb31250-cit-0018" publication-type="journal">
<string-name>
<surname>Hagberg</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Aicardi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Dias</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>Ramos</surname>, <given-names>O.</given-names>
</string-name> (<year>1983</year>). <article-title>A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>14</volume>, <fpage>471</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410140412</pub-id>
<pub-id pub-id-type="pmid">6638958</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0019">
<mixed-citation id="brb31250-cit-0019" publication-type="journal">
<string-name>
<surname>Hagberg</surname>, <given-names>B. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Skjeldal</surname>, <given-names>O. H.</given-names>
</string-name> (<year>1994</year>). <article-title>Rett variants: A suggested model for inclusion criteria</article-title>. <source xml:lang="en"/>Pediatric Neurology, <volume>11</volume>, <fpage>5</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/0887-8994(94)90082-5</pub-id>
<pub-id pub-id-type="pmid">7986294</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0020">
<mixed-citation id="brb31250-cit-0020" publication-type="journal">
<string-name>
<surname>Hagberg</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Stenbom</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Witt Engerstrom</surname>, <given-names>I.</given-names>
</string-name> (<year>2000</year>). <article-title>Head growth in Rett syndrome</article-title>. <source xml:lang="en"/>Acta Paediatrica, <volume>89</volume>, <fpage>198</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2000.tb01216.x</pub-id>
<pub-id pub-id-type="pmid">10709891</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0021">
<mixed-citation id="brb31250-cit-0021" publication-type="journal">
<string-name>
<surname>Hara</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ohba</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Yamashita</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Saitsu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Matsuishi</surname>, <given-names>T.</given-names>
</string-name> (<year>2015</year>). <article-title>De novo SHANK3 mutation causes Rett syndrome‐like phenotype in a female patient</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>167</volume>, <fpage>1593</fpage>–<lpage>1596</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36775</pub-id>
</mixed-citation>
</ref>
<ref id="brb31250-bib-0022">
<mixed-citation id="brb31250-cit-0022" publication-type="journal">
<string-name>
<surname>Henriksen</surname>, <given-names>M. W.</given-names>
</string-name>, <string-name>
<surname>Ravn</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Paus</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>von Tetzchner</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Skjeldal</surname>, <given-names>O. H.</given-names>
</string-name> (<year>2018</year>). <article-title>De novo mutations in SCN1A are associated with classic Rett syndrome: A case report</article-title>. <source xml:lang="en"/>Medical Genetics, <volume>19</volume>, <fpage>184</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-018-0700-z</pub-id>
<pub-id pub-id-type="pmid">30305042</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0023">
<mixed-citation id="brb31250-cit-0023" publication-type="journal">
<string-name>
<surname>Hoffjan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ibisler</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Tschentscher</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Dekomien</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Bidinost</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Rosa</surname>, <given-names>A. L.</given-names>
</string-name> (<year>2016</year>). <article-title>WDR45 mutations in Rett (‐like) syndrome and developmental delay: Case report and an appraisal of the literature</article-title>. <source xml:lang="en"/>Molecular and Cellular Probes, <volume>30</volume>, <fpage>44</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcp.2016.01.003</pub-id>
<pub-id pub-id-type="pmid">26790960</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0024">
<mixed-citation id="brb31250-cit-0024" publication-type="journal">
<string-name>
<surname>Huisman</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mulder</surname>, <given-names>P. A.</given-names>
</string-name>, <string-name>
<surname>Redeker</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Bader</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Bisgaard</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Hennekam</surname>, <given-names>R. C.</given-names>
</string-name> (<year>2017</year>). <article-title>Phenotypes and genotypes in individuals with SMC1A variants</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>173</volume>, <fpage>2108</fpage>–<lpage>2125</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38279</pub-id>
</mixed-citation>
</ref>
<ref id="brb31250-bib-0025">
<mixed-citation id="brb31250-cit-0025" publication-type="journal">
<string-name>
<surname>Imessaoudene</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Bonnefont</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<surname>Royer</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Cormier‐Daire</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Lyonnet</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Lyon</surname>, <given-names>G.</given-names>
</string-name>, … <string-name>
<surname>Amiel</surname>, <given-names>J.</given-names>
</string-name> (<year>2001</year>). <article-title>MECP2 mutation in non‐fatal, non‐progressive encephalopathy in a male</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>38</volume>, <fpage>171</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.38.3.171</pub-id>
<pub-id pub-id-type="pmid">11238684</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0026">
<mixed-citation id="brb31250-cit-0026" publication-type="journal">
<string-name>
<surname>Jeffrey L. Neul</surname>, </string-name>, <string-name>
<surname>Kaufmann</surname>, <given-names>W. E.</given-names>
</string-name>, <string-name>
<surname>Glaze</surname>, <given-names>D. G.</given-names>
</string-name>, <string-name>
<surname>Christodoulou</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Bahi‐Buisson</surname>, <given-names>N.</given-names>
</string-name>, … <string-name>
<surname>Percy</surname>, <given-names>A. K.</given-names>
</string-name> (<year>2010</year>). <article-title>Rett syndrome: Revised diagnostic criteria and nomenclature</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>68</volume>, <fpage>944</fpage>–<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22124</pub-id>
<pub-id pub-id-type="pmid">21154482</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0027">
<mixed-citation id="brb31250-cit-0027" publication-type="journal">
<string-name>
<surname>Jian</surname>, <given-names>L. e.</given-names>
</string-name>, <string-name>
<surname>Nagarajan</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>de Klerk</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Ravine</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Bower</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Leonard</surname>, <given-names>H.</given-names>
</string-name> (<year>2006</year>). <article-title>Predictors of seizure onset in Rett syndrome</article-title>. <source xml:lang="en"/>The Journal of Pediatrics, <volume>149</volume>, <fpage>542</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2006.06.015</pub-id>
<pub-id pub-id-type="pmid">17011329</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0028">
<mixed-citation id="brb31250-cit-0028" publication-type="journal">
<string-name>
<surname>Jian</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Nagarajan</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>de Klerk</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Ravine</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Christodoulou</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Leonard</surname>, <given-names>H.</given-names>
</string-name> (<year>2007</year>). <article-title>Seizures in Rett syndrome: An overview from a oneyear calendar study</article-title>. <source xml:lang="en"/>European Journal of Paediatric Neurology, <volume>11</volume>, <fpage>310</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2007.02.008</pub-id>
<pub-id pub-id-type="pmid">17433737</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0029">
<mixed-citation id="brb31250-cit-0029" publication-type="journal">
<string-name>
<surname>Jülich</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Horn</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Burfeind</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Erler</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Auber</surname>, <given-names>B.</given-names>
</string-name> (<year>2009</year>). <article-title>A novel MECP2 mutation in a boy with neonatal encephalopathy and facial dysmorphism</article-title>. <source xml:lang="en"/>The Journal of Pediatrics, <volume>155</volume>, <fpage>140</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2009.01.035</pub-id>
<pub-id pub-id-type="pmid">19559301</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0030">
<mixed-citation id="brb31250-cit-0030" publication-type="journal">
<string-name>
<surname>Jung</surname>, <given-names>B. P.</given-names>
</string-name>, <string-name>
<surname>Jugloff</surname>, <given-names>D. G. M.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Logan</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Brown</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Eubans</surname>, <given-names>J. H.</given-names>
</string-name> (<year>2003</year>). <article-title>The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells</article-title>. <source xml:lang="en"/>Journal of Neurobiology, <volume>55</volume>, <fpage>86</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/neu.10201</pub-id>
<pub-id pub-id-type="pmid">12605461</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0031">
<mixed-citation id="brb31250-cit-0031" publication-type="journal">
<string-name>
<surname>Knudsen</surname>, <given-names>G. P. S.</given-names>
</string-name>, <string-name>
<surname>Neilson</surname>, <given-names>T. C. S.</given-names>
</string-name>, <string-name>
<surname>Pederson</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Kerr</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hulten</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Ørstavik</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2006</year>). <article-title>Increased skewing of X chrosome inactivation in Rett syndrome patients and their mothers</article-title>. <source xml:lang="en"/>European Journal of Human Genetics, <volume>14</volume>, <fpage>1189</fpage>–<lpage>1194</lpage>.<pub-id pub-id-type="pmid">16823396</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0032">
<mixed-citation id="brb31250-cit-0032" publication-type="journal">
<string-name>
<surname>Kortüm</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Das</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Flindt</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Morris‐Rosendahl</surname>, <given-names>D. J.</given-names>
</string-name>, <string-name>
<surname>Stefanova</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Goldstein</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Dobyns</surname>, <given-names>W. B.</given-names>
</string-name> (<year>2011</year>). <article-title>The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>48</volume>, <fpage>396</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2010.087528</pub-id>
<pub-id pub-id-type="pmid">21441262</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0033">
<mixed-citation id="brb31250-cit-0033" publication-type="journal">
<string-name>
<surname>Krajnc</surname>, <given-names>N.</given-names>
</string-name> (<year>2015</year>). <article-title>Management of epilepsy in patients with Rett syndrome: Perspectives and considerations</article-title>. <source xml:lang="en"/>Therapeutics and Clinical Risk Management, <volume>11</volume>, <fpage>925</fpage>–<lpage>932</lpage>. <pub-id pub-id-type="doi">10.2147/TCRM.S55896</pub-id>
<pub-id pub-id-type="pmid">26089674</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0034">
<mixed-citation id="brb31250-cit-0034" publication-type="journal">
<string-name>
<surname>Kyle</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Vashi</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Justice</surname>, <given-names>M. J.</given-names>
</string-name> (<year>2018</year>). <article-title>Rett syndrome: A neurological disorder with metabolic components</article-title>. <source xml:lang="en"/>Open Biology, <volume>8</volume>, <fpage>170216</fpage>
<pub-id pub-id-type="doi">10.1098/rsob.170216</pub-id>
<pub-id pub-id-type="pmid">29445033</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0035">
<mixed-citation id="brb31250-cit-0035" publication-type="journal">
<string-name>
<surname>Lee</surname>, <given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Lim</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Choi</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Chae</surname>, <given-names>J. H.</given-names>
</string-name> (<year>2016</year>). <article-title>SATB2‐associated syndrome presenting with Rett‐like phenotypes</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>89</volume>, <fpage>728</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12698</pub-id>
<pub-id pub-id-type="pmid">26596517</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0036">
<mixed-citation id="brb31250-cit-0036" publication-type="journal">
<string-name>
<surname>Lopes</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Barbosa</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ameur</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Soares</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>deSá</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Dias</surname>, <given-names>A. I.</given-names>
</string-name>, … <string-name>
<surname>Maciel</surname>, <given-names>P.</given-names>
</string-name> (<year>2016</year>). <article-title>Identification of novel genetic causes of Rett syndrome‐like phenotypes</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>53</volume>, <fpage>190</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103568</pub-id>
<pub-id pub-id-type="pmid">26740508</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0037">
<mixed-citation id="brb31250-cit-0037" publication-type="journal">
<string-name>
<surname>Lucariello</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Vidal</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Vidal</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Saez</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Roa</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Huertas</surname>, <given-names>D.</given-names>
</string-name>, … <string-name>
<surname>Esteller</surname>, <given-names>M.</given-names>
</string-name> (<year>2016</year>). <article-title>Whole exome sequencing of Rett syndrome‐like patients reveals the mutational diversity of the clinical phenotype</article-title>. <source xml:lang="en"/>Human Genetics, <volume>135</volume>, <fpage>1343</fpage>–<lpage>1354</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-016-1721-3</pub-id>
<pub-id pub-id-type="pmid">27541642</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0038">
<mixed-citation id="brb31250-cit-0038" publication-type="journal">
<string-name>
<surname>Mari</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Azimonti</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bertani</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Bolognese</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Colombo</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Caselli</surname>, <given-names>R.</given-names>
</string-name>, … <string-name>
<surname>Landsberger</surname>, <given-names>N.</given-names>
</string-name> (<year>2005</year>). <article-title>CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early‐onset seizure variant of Rett syndrome</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>14</volume>(<issue>14</issue>), <fpage>1935</fpage>–<lpage>1946</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi198</pub-id>
<pub-id pub-id-type="pmid">15917271</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0039">
<mixed-citation id="brb31250-cit-0039" publication-type="journal">
<string-name>
<surname>Matijievic</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Knezevic</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Slavica</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Pavelic</surname>, <given-names>J.</given-names>
</string-name> (<year>2009</year>). <article-title>Rett syndrome: From the gene to the disease</article-title>. <source xml:lang="en"/>European Neurology, <volume>61</volume>, <fpage>3</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1159/000165342</pub-id>
<pub-id pub-id-type="pmid">18948693</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0040">
<mixed-citation id="brb31250-cit-0040" publication-type="journal">
<string-name>
<surname>Melani</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Mei</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Pisano</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Savasta</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Franzoni</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ferrari</surname>, <given-names>A. R.</given-names>
</string-name>, … <string-name>
<surname>Guerrini</surname>, <given-names>R.</given-names>
</string-name> (<year>2011</year>). <article-title>CDKL5 gene‐related epileptic encephalopathy: Electroclinical findings in the first year of life</article-title>. <source xml:lang="en"/>Developmental Medicine &amp; Child Neurology, <volume>53</volume>, <fpage>354</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2010.03889.x</pub-id>
<pub-id pub-id-type="pmid">21309761</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0041">
<mixed-citation id="brb31250-cit-0041" publication-type="journal">
<string-name>
<surname>Meloni</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Bruttini</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Longo</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Mari</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Rizzolio</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>D'Adamo</surname>, <given-names>P.</given-names>
</string-name>, … <string-name>
<surname>Renieri</surname>, <given-names>A.</given-names>
</string-name> (<year>2000</year>). <article-title>A mutation in the rett syndrome gene, MECP2, causes X‐linked mental retardation and progressive spasticity in males</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>67</volume>, <fpage>982</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1086/303078</pub-id>
<pub-id pub-id-type="pmid">10986043</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0042">
<mixed-citation id="brb31250-cit-0042" publication-type="journal">
<string-name>
<surname>Moser</surname>, <given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>Weber</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Lutschg</surname>, <given-names>J.</given-names>
</string-name> (<year>2007</year>). <article-title>Rett syndrome: Clinical and electrophysiologic aspects</article-title>. <source xml:lang="en"/>Pediatric Neurology, <volume>36</volume>(<issue>2</issue>), <fpage>95</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2006.10.003</pub-id>
<pub-id pub-id-type="pmid">17275660</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0043">
<mixed-citation id="brb31250-cit-0043" publication-type="journal">
<string-name>
<surname>Nectoux</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Bahi‐Buisson</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Guellec</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Coste</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Roux</surname>, <given-names>N. d.</given-names>
</string-name>, <string-name>
<surname>Rosas</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Bienvenu</surname>, <given-names>T.</given-names>
</string-name> (<year>2008</year>). <article-title>The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome</article-title>. <source xml:lang="en"/>Neurology, <volume>70</volume>, <fpage>2145</fpage>–<lpage>2151</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000304086.75913.b2</pub-id>
<pub-id pub-id-type="pmid">18434641</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0044">
<mixed-citation id="brb31250-cit-0044" publication-type="journal">
<string-name>
<surname>Neul</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Fang</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Barrish</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Lane</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Caeg</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Smith</surname>, <given-names>E. O.</given-names>
</string-name>, … <string-name>
<surname>Glaze</surname>, <given-names>D. G.</given-names>
</string-name> (<year>2008</year>). <article-title>Specific mutations in Methyl‐CpG‐binding protein 2 confer different severity in Rett syndrome</article-title>. <source xml:lang="en"/>Neurology, <volume>70</volume>, <fpage>1313</fpage>–<lpage>1321</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000291011.54508.aa</pub-id>
<pub-id pub-id-type="pmid">18337588</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0045">
<mixed-citation id="brb31250-cit-0045" publication-type="journal">
<string-name>
<surname>Nissenkorn</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gak</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Vecsler</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Reznik</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Menascu</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Ben Zeev</surname>, <given-names>B.</given-names>
</string-name> (<year>2010</year>). <article-title>Epilepsy in Rett syndrome‐The experience of a National Rett Center</article-title>. <source xml:lang="en"/>Epilepsia, <volume>51</volume>, <fpage>1252</fpage>–<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02597.x</pub-id>
<pub-id pub-id-type="pmid">20491871</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0046">
<mixed-citation id="brb31250-cit-0046" publication-type="journal">
<string-name>
<surname>Okamoto</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Miya</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Tsunoda</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Kato</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Saitoh</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Yamasaki</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Kosaki</surname>, <given-names>K.</given-names>
</string-name> (<year>2015</year>). <article-title>Targeted next‐generation sequencing in the diagnosis of neurodevelopmental disorders</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>88</volume>, <fpage>288</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1111/cge.12492</pub-id>
<pub-id pub-id-type="pmid">25156961</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0047">
<mixed-citation id="brb31250-cit-0047" publication-type="journal">
<string-name>
<surname>Olson</surname>, <given-names>H. E.</given-names>
</string-name>, <string-name>
<surname>Tambunan</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>LaCoursiere</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Goldenberg</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Pinsky</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Poduri</surname>, <given-names>A.</given-names>
</string-name> (<year>2015</year>). <article-title>Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics, <volume>167A</volume>, <fpage>2017</fpage>–<lpage>2025</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37132</pub-id>
<pub-id pub-id-type="pmid">25914188</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0048">
<mixed-citation id="brb31250-cit-0048" publication-type="journal">
<string-name>
<surname>Percy</surname>, <given-names>A. K.</given-names>
</string-name>, <string-name>
<surname>Lane</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Annese</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Warren</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>S. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Neul</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2018</year>). <article-title>When Rett syndrome is due to genes other than MECP2</article-title>. <source xml:lang="en"/>Translational Science of Rare Disease, <volume>3</volume>, <fpage>49</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.3233/TRD-180021</pub-id>
</mixed-citation>
</ref>
<ref id="brb31250-bib-0049">
<mixed-citation id="brb31250-cit-0049" publication-type="journal">
<string-name>
<surname>Percy</surname>, <given-names>A. K.</given-names>
</string-name>, <string-name>
<surname>Neul</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Glaze</surname>, <given-names>D. G.</given-names>
</string-name>, <string-name>
<surname>Motil</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Khwaja</surname>, <given-names>O.</given-names>
</string-name>, … <string-name>
<surname>Barnes</surname>, <given-names>K.</given-names>
</string-name> (<year>2010</year>). <article-title>Rett syndrome diagnostic criteria: Lessons from the Natural History Study</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>68</volume>, <fpage>951</fpage>–<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22154</pub-id>
<pub-id pub-id-type="pmid">21104896</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0050">
<mixed-citation id="brb31250-cit-0050" publication-type="journal">
<string-name>
<surname>Pintaudi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Calevo</surname>, <given-names>M. G.</given-names>
</string-name>, <string-name>
<surname>Vignoli</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Parodi</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Aiello</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Baglietto</surname>, <given-names>M. G.</given-names>
</string-name>, … <string-name>
<surname>Veneselli</surname>, <given-names>E.</given-names>
</string-name> (<year>2010</year>). <article-title>Epilepsy in Rettsyndrome: Clinical and geneticfeatures</article-title>. <source xml:lang="en"/>Epilepsy Behavior, <volume>19</volume>, <fpage>296</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2010.06.051</pub-id>
<pub-id pub-id-type="pmid">20728410</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0051">
<mixed-citation id="brb31250-cit-0051" publication-type="journal">
<string-name>
<surname>Ramocki</surname>, <given-names>M. B.</given-names>
</string-name>, <string-name>
<surname>Peters</surname>, <given-names>S. U.</given-names>
</string-name>, <string-name>
<surname>Tavyev</surname>, <given-names>Y. J.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Carvalho</surname>, <given-names>C. M. B.</given-names>
</string-name>, <string-name>
<surname>Schaaf</surname>, <given-names>C. P.</given-names>
</string-name>, &amp; <string-name>
<surname>Zoghbi</surname>, <given-names>H. Y.</given-names>
</string-name> (<year>2009</year>). <article-title>Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2 duplication syndrome</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>66</volume>, <fpage>771</fpage>–<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21715</pub-id>
<pub-id pub-id-type="pmid">20035514</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0052">
<mixed-citation id="brb31250-cit-0052" publication-type="journal">
<string-name>
<surname>Rett</surname>, <given-names>A.</given-names>
</string-name> (<year>1966</year>). <article-title>On a unusual brain atrophy syndrome in hyperammonemia in childhood</article-title>. <source xml:lang="en"/>Wiener Medizinische Wochenschrift, <volume>116</volume>(<issue>37</issue>), <fpage>723</fpage>–<lpage>726</lpage>.<pub-id pub-id-type="pmid">5300597</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0053">
<mixed-citation id="brb31250-cit-0053" publication-type="journal">
<string-name>
<surname>Rusconi</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Salvatoni</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Giudici</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Bertani</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Kilstrup‐Nielsen</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Broccoli</surname>, <given-names>V.</given-names>
</string-name>, &amp; <string-name>
<surname>Landsberger</surname>, <given-names>N.</given-names>
</string-name> (<year>2008</year>). <article-title>CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C‐terminal tail</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>283</volume>, <fpage>30101</fpage>–<lpage>30111</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M804613200</pub-id>
<pub-id pub-id-type="pmid">18701457</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0054">
<mixed-citation id="brb31250-cit-0054" publication-type="journal">
<string-name>
<surname>Sáez</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Fernández‐Rodríguez</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Moutinho</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Sanchez‐Mut</surname>, <given-names>J. V.</given-names>
</string-name>, <string-name>
<surname>Gomez</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vidal</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Esteller</surname>, <given-names>M.</given-names>
</string-name> (<year>2016</year>). <article-title>Mutations in JMJD1C are involved in Rett syndrome and intellectual disability</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>18</volume>, <fpage>378</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.100</pub-id>
<pub-id pub-id-type="pmid">26181491</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0055">
<mixed-citation id="brb31250-cit-0055" publication-type="journal">
<string-name>
<surname>Saitsu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Tohyama</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Walsh</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Kato</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>, <given-names>Y. u.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Matsumoto</surname>, <given-names>N.</given-names>
</string-name> (<year>2014</year>). <article-title>A girl with West syndrome and autistic features harboring a de novo TBL1XR1 mutation</article-title>. <source xml:lang="en"/>Journal of Human Genetics, <volume>59</volume>, <fpage>581</fpage>–<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2014.71</pub-id>
<pub-id pub-id-type="pmid">25102098</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0056">
<mixed-citation id="brb31250-cit-0056" publication-type="journal">
<string-name>
<surname>Sajan</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Jhangiani</surname>, <given-names>S. N.</given-names>
</string-name>, <string-name>
<surname>Muzny</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Gibbs</surname>, <given-names>R. A.</given-names>
</string-name>, <string-name>
<surname>Lupski</surname>, <given-names>J. R.</given-names>
</string-name>, <string-name>
<surname>Glaze</surname>, <given-names>D. G.</given-names>
</string-name>, … <string-name>
<surname>Neul</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2017</year>). <article-title>Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2</article-title>. <source xml:lang="en"/>Genetics in Medicine, <volume>19</volume>, <fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2016.42</pub-id>
<pub-id pub-id-type="pmid">27171548</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0057">
<mixed-citation id="brb31250-cit-0057" publication-type="journal">
<string-name>
<surname>Samaco</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Nagarajan</surname>, <given-names>R. P.</given-names>
</string-name>, <string-name>
<surname>Braunschweig</surname>, <given-names>D.</given-names>
</string-name>, &amp; <string-name>
<surname>LaSalle</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2004</year>). <article-title>Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism‐spectrum disorders</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>13</volume>, <fpage>629</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh063</pub-id>
<pub-id pub-id-type="pmid">14734626</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0058">
<mixed-citation id="brb31250-cit-0058" publication-type="journal">
<string-name>
<surname>Scala</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Ariani</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Mari</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Caselli</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Pescucci</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Longo</surname>, <given-names>I.</given-names>
</string-name>, … <string-name>
<surname>Renieri</surname>, <given-names>A.</given-names>
</string-name> (<year>2005</year>). <article-title>CDKL5/STK9 ismutated in Rettsyndromevariant with infantile spasms</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>42</volume>(<issue>2</issue>), <fpage>103</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2004.026237</pub-id>
<pub-id pub-id-type="pmid">15689447</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0059">
<mixed-citation id="brb31250-cit-0059" publication-type="journal">
<string-name>
<surname>Schwartzman</surname>, <given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Bernardino</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Nishimura</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gomes</surname>, <given-names>R. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Zatz</surname>, <given-names>M.</given-names>
</string-name> (<year>2001</year>). <article-title>Rett syndrome in a boy with a 47, XXY karyotype confirmed by a rare mutation in the MECP2 gene</article-title>. <source xml:lang="en"/>Neuropediatrics, <volume>32</volume>, <fpage>162</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1055/s-2001-16620</pub-id>
<pub-id pub-id-type="pmid">11521215</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0060">
<mixed-citation id="brb31250-cit-0060" publication-type="journal">
<string-name>
<surname>Steffenburg</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>Hagberg</surname>, <given-names>G.</given-names>
</string-name>, &amp; <string-name>
<surname>Hagberg</surname>, <given-names>B.</given-names>
</string-name> (<year>2001</year>). <article-title>Epilepsy in a representative series of Rett syndrome</article-title>. <source xml:lang="en"/>Acta Paediatrica, <volume>90</volume>, <fpage>34</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2001.tb00252.x</pub-id>
<pub-id pub-id-type="pmid">11227330</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0061">
<mixed-citation id="brb31250-cit-0061" publication-type="journal">
<string-name>
<surname>Striano</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Paravidino</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Sicca</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Chiurazzi</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Gimelli</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Coppola</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Zara</surname>, <given-names>F.</given-names>
</string-name> (<year>2011</year>). <article-title>West syndromeassociated with 14q12 duplicationsharboring FOXG1</article-title>. <source xml:lang="en"/>Neurology, <volume>76</volume>, <fpage>1600</fpage>–<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182194bbf</pub-id>
<pub-id pub-id-type="pmid">21536641</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0062">
<mixed-citation id="brb31250-cit-0062" publication-type="journal">
<string-name>
<surname>Tarquinio</surname>, <given-names>D. C.</given-names>
</string-name>, <string-name>
<surname>Hou</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Berg</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Kaufmann</surname>, <given-names>W. E.</given-names>
</string-name>, <string-name>
<surname>Lane</surname>, <given-names>J. B.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>S. A.</given-names>
</string-name>, … <string-name>
<surname>Glaze</surname>, <given-names>D. G.</given-names>
</string-name> (<year>2017</year>). <article-title>Longitudinal course of epilepsy in Rett syndrome and related disorders</article-title>. <source xml:lang="en"/>Brain, <volume>140</volume>, <fpage>306</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww302</pub-id>
<pub-id pub-id-type="pmid">28007990</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0063">
<mixed-citation id="brb31250-cit-0063" publication-type="journal">
<string-name>
<surname>Topҫu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Akyerli</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Sayi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Tӧrüner</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Koҫoğlu</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Cimbiş</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Ozҫelik</surname>, <given-names>T.</given-names>
</string-name> (<year>2002</year>). <article-title>Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <volume>10</volume>, <fpage>77</fpage>–<lpage>81</lpage>.</mixed-citation>
</ref>
<ref id="brb31250-bib-0064">
<mixed-citation id="brb31250-cit-0064" publication-type="journal">
<string-name>
<surname>Trappe</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Laccone</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Cobilanschi</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Meins</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Huppke</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Hanefeld</surname>, <given-names>F.</given-names>
</string-name>, &amp; <string-name>
<surname>Engel</surname>, <given-names>W.</given-names>
</string-name> (<year>2001</year>). <article-title>MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>68</volume>, <fpage>1093</fpage>–<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1086/320109</pub-id>
<pub-id pub-id-type="pmid">11309679</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0065">
<mixed-citation id="brb31250-cit-0065" publication-type="journal">
<string-name>
<surname>Van Esch</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bauters</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ignatius</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Jansen</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Raynaud</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hollanders</surname>, <given-names>K.</given-names>
</string-name>, … <string-name>
<surname>Froyen</surname>, <given-names>G.</given-names>
</string-name> (<year>2005</year>). <article-title>Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>77</volume>, <fpage>442</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1086/444549</pub-id>
<pub-id pub-id-type="pmid">16080119</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0066">
<mixed-citation id="brb31250-cit-0066" publication-type="journal">
<string-name>
<surname>Vidal</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Brandi</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Pacheco</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Gerotina</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Blasco</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Trotta</surname>, <given-names>J.‐R.</given-names>
</string-name>, … <string-name>
<surname>Armstrong</surname>, <given-names>J.</given-names>
</string-name> (<year>2017</year>). <article-title>The utility of next generation sequencing for molecular diagnostics in Rett syndrome</article-title>. <source xml:lang="en"/>Scientific Reports, <volume>7</volume>, <fpage>12288</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-11620-3</pub-id>
<pub-id pub-id-type="pmid">28947817</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0067">
<mixed-citation id="brb31250-cit-0067" publication-type="journal">
<string-name>
<surname>Wan</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>S. S.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Houwink‐Manville</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Song</surname>, <given-names>H. R.</given-names>
</string-name>, <string-name>
<surname>Amir</surname>, <given-names>R. E.</given-names>
</string-name>, … <string-name>
<surname>Francke</surname>, <given-names>U.</given-names>
</string-name> (<year>1999</year>). <article-title>Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>65</volume>, <fpage>1520</fpage>–<lpage>1529</lpage>. <pub-id pub-id-type="doi">10.1086/302690</pub-id>
<pub-id pub-id-type="pmid">10577905</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0068">
<mixed-citation id="brb31250-cit-0068" publication-type="journal">
<string-name>
<surname>Weaving</surname>, <given-names>L. S.</given-names>
</string-name>, <string-name>
<surname>Christodoulou</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Williamson</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Friend</surname>, <given-names>K. L.</given-names>
</string-name>, <string-name>
<surname>McKenzie</surname>, <given-names>O. L.</given-names>
</string-name>, <string-name>
<surname>Archer</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Gécz</surname>, <given-names>J.</given-names>
</string-name> (<year>2004</year>). <article-title>Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasm and mental retardation</article-title>. <source xml:lang="en"/>American Journal of Human Genetics, <volume>75</volume>, <fpage>1079</fpage>–<lpage>1093</lpage>. <pub-id pub-id-type="doi">10.1086/426462</pub-id>
<pub-id pub-id-type="pmid">15492925</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0069">
<mixed-citation id="brb31250-cit-0069" publication-type="journal">
<string-name>
<surname>Yeung</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bruno</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Scheffer</surname>, <given-names>I. E.</given-names>
</string-name>, <string-name>
<surname>Carranza</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Burgess</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Slater</surname>, <given-names>H. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Amor</surname>, <given-names>D. J.</given-names>
</string-name> (<year>2009</year>). <article-title>4.45 Mb microduplication in chromosome band 14q12 including FOXG1 in a girl with refractory epilepsy and intellectual impairment</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <volume>52</volume>, <fpage>440</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">19772934</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0070">
<mixed-citation id="brb31250-cit-0070" publication-type="journal">
<string-name>
<surname>Yoo</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Jung</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>Y. N.</given-names>
</string-name>, <string-name>
<surname>Lee</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Cho</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Na</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Choi</surname>, <given-names>M.</given-names>
</string-name> (<year>2017</year>). <article-title>GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>82</volume>, <fpage>466</fpage>–<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1002/ana.25032</pub-id>
<pub-id pub-id-type="pmid">28856709</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0071">
<mixed-citation id="brb31250-cit-0071" publication-type="journal">
<string-name>
<surname>Yuge</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Iwama</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Yonee</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Matsufuji</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sano</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Saikusa</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>Matsuishi</surname>, <given-names>T.</given-names>
</string-name> (<year>2018</year>). <article-title>A novel STXBP1 mutation causes typical Rett syndrome in a Japanese girl</article-title>. <source xml:lang="en"/>Brain and Development, <volume>40</volume>(<issue>6</issue>), <fpage>493</fpage>–<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2018.02.002</pub-id>
<pub-id pub-id-type="pmid">29544889</pub-id></mixed-citation>
</ref>
<ref id="brb31250-bib-0073">
<mixed-citation id="brb31250-cit-0073" publication-type="journal">
<string-name>
<surname>Zeev</surname>, <given-names>B. B.</given-names>
</string-name>, <string-name>
<surname>Yaron</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Schanen</surname>, <given-names>N. C.</given-names>
</string-name>, <string-name>
<surname>Wolf</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Brandt</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Ginot</surname>, <given-names>N.</given-names>
</string-name>, … <string-name>
<surname>Orr‐Urtreger</surname>, <given-names>A.</given-names>
</string-name> (<year>2002</year>). <article-title>Rett syndrome: Clinical manifestations in males with MECP2 mutations</article-title>. <source xml:lang="en"/>Journal of Child Neurology, <volume>17</volume>, <fpage>20</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1177/088307380201700105</pub-id>
<pub-id pub-id-type="pmid">11913564</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>